Lymphoma Clinical Trial
Official title:
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease
| Verified date | May 2013 |
| Source | Southwest Oncology Group |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | United States: Federal Government |
| Study type | Observational |
RATIONALE: Collecting and storing samples of tissue from patients with non-Hodgkin lymphoma
to study in the laboratory may help the study of cancer in the future.
PURPOSE: This laboratory study is collecting and storing tissue samples from patients with
relapsed or recurrent non-Hodgkin lymphoma after treatment on a Southwest Oncology Group
(SWOG) clinical trial.
| Status | Completed |
| Enrollment | 32 |
| Est. completion date | July 2011 |
| Est. primary completion date | July 2011 |
| Accepts healthy volunteers | No |
| Gender | Both |
| Age group | 18 Years and older |
| Eligibility |
DISEASE CHARACTERISTICS: - Diagnosis of relapsed or recurrent non-Hodgkin lymphoma (NHL) - Previously registered on 1 of the following SWOG clinical trials for previously untreated NHL: - SWOG-8410 - SWOG-8503 - SWOG-8508 - SWOG-8516 - SWOG-8736 - SWOG-8809 - SWOG-8907 - SWOG-8954 - SWOG-9125 - SWOG-9240 - SWOG-9320 - SWOG-9349 - SWOG-9432 - SWOG-9501 - SWOG-9703 - SWOG-S9704 - SWOG-9800 - Tissue samples of relapsed or recurrent disease available PATIENT CHARACTERISTICS: - Not specified PRIOR CONCURRENT THERAPY: - See Disease Characteristics |
Time Perspective: Retrospective
| Country | Name | City | State |
|---|---|---|---|
| United States | Alaska Regional Hospital Cancer Center | Anchorage | Alaska |
| United States | CCOP - Atlanta Regional | Atlanta | Georgia |
| United States | Northside Hospital Cancer Center | Atlanta | Georgia |
| United States | Piedmont Hospital | Atlanta | Georgia |
| United States | Saint Joseph's Hospital of Atlanta | Atlanta | Georgia |
| United States | WellStar Cobb Hospital | Austell | Georgia |
| United States | Mary Rutan Hospital | Bellefontaine | Ohio |
| United States | St. Joseph Cancer Center | Bellingham | Washington |
| United States | Billings Clinic - Downtown | Billings | Montana |
| United States | CCOP - Montana Cancer Consortium | Billings | Montana |
| United States | Hematology-Oncology Centers of the Northern Rockies - Billings | Billings | Montana |
| United States | Northern Rockies Radiation Oncology Center | Billings | Montana |
| United States | St. Vincent Healthcare Cancer Care Services | Billings | Montana |
| United States | Bozeman Deaconess Cancer Center | Bozeman | Montana |
| United States | Olympic Hematology and Oncology | Bremerton | Washington |
| United States | St. James Healthcare Cancer Care | Butte | Montana |
| United States | Rocky Mountain Oncology | Casper | Wyoming |
| United States | Adena Regional Medical Center | Chillicothe | Ohio |
| United States | Clackamas Radiation Oncology Center | Clackamas | Oregon |
| United States | CCOP - Columbus | Columbus | Ohio |
| United States | Doctors Hospital at Ohio Health | Columbus | Ohio |
| United States | Grant Medical Center Cancer Care | Columbus | Ohio |
| United States | John B. Amos Cancer Center | Columbus | Georgia |
| United States | Mount Carmel Health - West Hospital | Columbus | Ohio |
| United States | Riverside Methodist Hospital Cancer Care | Columbus | Ohio |
| United States | Genesis Regional Cancer Center at Genesis Medical Center | Davenport | Iowa |
| United States | Charles B. Eberhart Cancer Center at DeKalb Medical Center | Decatur | Georgia |
| United States | Grady Memorial Hospital | Delaware | Ohio |
| United States | Josephine Ford Cancer Center at Henry Ford Hospital | Detroit | Michigan |
| United States | Piedmont Fayette Hospital | Fayetteville | Georgia |
| United States | McLeod Regional Medical Center | Florence | South Carolina |
| United States | Big Sky Oncology | Great Falls | Montana |
| United States | Great Falls Clinic - Main Facility | Great Falls | Montana |
| United States | Sletten Cancer Institute at Benefis Healthcare | Great Falls | Montana |
| United States | Northern Montana Hospital | Havre | Montana |
| United States | St. Peter's Hospital | Helena | Montana |
| United States | University of Mississippi Cancer Clinic | Jackson | Mississippi |
| United States | Glacier Oncology, PLLC | Kalispell | Montana |
| United States | Kalispell Medical Oncology at KRMC | Kalispell | Montana |
| United States | Kalispell Regional Medical Center | Kalispell | Montana |
| United States | Columbia Basin Hematology | Kennewick | Washington |
| United States | Fairfield Medical Center | Lancaster | Ohio |
| United States | Gwinnett Medical Center | Lawrenceville | Georgia |
| United States | Kennestone Cancer Center at Wellstar Kennestone Hospital | Marietta | Georgia |
| United States | Strecker Cancer Center at Marietta Memorial Hospital | Marietta | Ohio |
| United States | Providence Milwaukie Hospital | Milwaukie | Oregon |
| United States | Montana Cancer Center at St. Patrick Hospital and Health Sciences Center | Missoula | Montana |
| United States | Montana Cancer Specialists at Montana Cancer Center | Missoula | Montana |
| United States | Louisiana State University Health Sciences Center - Monroe | Monroe | Louisiana |
| United States | Knox Community Hospital | Mount Vernon | Ohio |
| United States | Skagit Valley Hospital Cancer Care Center | Mt. Vernon | Washington |
| United States | Licking Memorial Cancer Care Program at Licking Memorial Hospital | Newark | Ohio |
| United States | Providence Newberg Medical Center | Newberg | Oregon |
| United States | Willamette Falls Hospital | Oregon City | Oregon |
| United States | Adventist Medical Center | Portland | Oregon |
| United States | CCOP - Columbia River Oncology Program | Portland | Oregon |
| United States | Providence Cancer Center at Providence Portland Medical Center | Portland | Oregon |
| United States | Providence St. Vincent Medical Center | Portland | Oregon |
| United States | Harrison Poulsbo Hematology and Onocology | Poulsbo | Washington |
| United States | Southern Regional Medical Center | Riverdale | Georgia |
| United States | Harbin Clinic Cancer Center - Medical Oncology | Rome | Georgia |
| United States | Salem Hospital Regional Cancer Care Services | Salem | Oregon |
| United States | University Hospital - San Antonio | San Antonio | Texas |
| United States | University of Texas Health Science Center at San Antonio | San Antonio | Texas |
| United States | Veterans Affairs Medical Center - San Antonio (Murphy) | San Antonio | Texas |
| United States | Fred Hutchinson Cancer Research Center | Seattle | Washington |
| United States | Group Health Central Hospital | Seattle | Washington |
| United States | Harborview Medical Center | Seattle | Washington |
| United States | Minor and James Medical, PLLC | Seattle | Washington |
| United States | Polyclinic First Hill | Seattle | Washington |
| United States | Swedish Cancer Institute at Swedish Medical Center - First Hill Campus | Seattle | Washington |
| United States | University Cancer Center at University of Washington Medical Center | Seattle | Washington |
| United States | Welch Cancer Center at Sheridan Memorial Hospital | Sheridan | Wyoming |
| United States | Feist-Weiller Cancer Center at Louisiana State University Health Sciences | Shreveport | Louisiana |
| United States | Cancer Care Northwest - Spokane South | Spokane | Washington |
| United States | Evergreen Hematology and Oncology, PS | Spokane | Washington |
| United States | Community Hospital of Springfield and Clark County | Springfield | Ohio |
| United States | Cotton-O'Neil Cancer Center | Topeka | Kansas |
| United States | Southwest Washington Medical Center Cancer Center | Vancouver | Washington |
| United States | Wenatchee Valley Medical Center | Wenatchee | Washington |
| United States | Mount Carmel St. Ann's Cancer Center | Westerville | Ohio |
| United States | Genesis - Good Samaritan Hospital | Zanesville | Ohio |
| Lead Sponsor | Collaborator |
|---|---|
| Southwest Oncology Group | National Cancer Institute (NCI) |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Acquisition of snap-frozen lymphoma tissues | July 2011 | No |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Recruiting |
NCT05540340 -
A Study of Melphalan in People With Lymphoma Getting an Autologous Hematopoietic Cell Transplant
|
Phase 1 | |
| Completed |
NCT01947140 -
Pralatrexate + Romidepsin in Relapsed/Refractory Lymphoid Malignancies
|
Phase 1/Phase 2 | |
| Completed |
NCT00001512 -
Active Specific Immunotherapy for Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype Antigen Vaccines
|
Phase 1 | |
| Recruiting |
NCT05618041 -
The Safety and Efficay Investigation of CAR-T Cell Therapy for Patients With Hematological Malignancies
|
N/A | |
| Completed |
NCT01410630 -
FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma
|
||
| Active, not recruiting |
NCT04270266 -
Mind-Body Medicine for the Improvement of Quality of Life in Adolescents and Young Adults Coping With Lymphoma
|
N/A | |
| Terminated |
NCT00801931 -
Double Cord Blood Transplant for Patients With Malignant and Non-malignant Disorders
|
Phase 1/Phase 2 | |
| Completed |
NCT01949883 -
A Phase 1 Study Evaluating CPI-0610 in Patients With Progressive Lymphoma
|
Phase 1 | |
| Completed |
NCT01682226 -
Cord Blood With T-Cell Depleted Haplo-identical Peripheral Blood Stem Cell Transplantation for Hematological Malignancies
|
Phase 2 | |
| Completed |
NCT00003270 -
Chemotherapy, Radiation Therapy, and Umbilical Cord Blood Transplantation in Treating Patients With Hematologic Cancer
|
Phase 2 | |
| Recruiting |
NCT04904588 -
HLA-Mismatched Unrelated Donor Hematopoietic Cell Transplantation With Post-Transplantation Cyclophosphamide
|
Phase 2 | |
| Recruiting |
NCT05019976 -
Radiation Dose Study for Relapsed/Refractory Hodgkin/Non-Hodgkin Lymphoma
|
N/A | |
| Completed |
NCT04434937 -
Open-Label Study of Parsaclisib, in Japanese Participants With Relapsed or Refractory Follicular Lymphoma (CITADEL-213)
|
Phase 2 | |
| Completed |
NCT01855750 -
A Study of the Bruton's Tyrosine Kinase Inhibitor, PCI-32765 (Ibrutinib), in Combination With Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Patients With Newly Diagnosed Non-Germinal Center B-Cell Subtype of Diffuse Large B-Cell Lymphoma
|
Phase 3 | |
| Terminated |
NCT00788125 -
Dasatinib, Ifosfamide, Carboplatin, and Etoposide in Treating Young Patients With Metastatic or Recurrent Malignant Solid Tumors
|
Phase 1/Phase 2 | |
| Terminated |
NCT00775268 -
18F- Fluorothymidine to Evaluate Treatment Response in Lymphoma
|
Phase 1/Phase 2 | |
| Active, not recruiting |
NCT04188678 -
Resiliency in Older Adults Undergoing Bone Marrow Transplant
|
N/A | |
| Terminated |
NCT00014560 -
Antibody Therapy in Treating Patients With Refractory or Relapsed Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
|
Phase 1 | |
| Recruiting |
NCT04977024 -
SARS-CoV-2 Vaccine (GEO-CM04S1) Versus mRNA SARS-COV-2 Vaccine in Patients With Blood Cancer
|
Phase 2 | |
| Active, not recruiting |
NCT03936465 -
Study of the Bromodomain (BRD) and Extra-Terminal Domain (BET) Inhibitors BMS-986158 and BMS-986378 in Pediatric Cancer
|
Phase 1 |